The activity of this well-characterised effector pathway downstream of mTOR is reduced in AD due to the hyperactivation of the PI3K/Akt/mTOR axis, resulting in the reduced clearance and accumulation of protein aggregates. This evidence concerns the gene AKT1 and Alzheimer disease.